glp 1 receptor agonists incretin mimetics Incretin-Based Therapies Through the Decades: Molecular Innovations and Clinical Impact You might've heard of this
Description
Other than direct consequences, such as degenerative arthritis and sleep apnea, its controversial whether being overweight in and of itself causes a health risk
Being obese with a body mass index of over 25 kg/m also increases the risk of diabetes
For weight loss, Tirzepatide delivers excellent results, but whats best for you depends on many factors, such as how much weight you want to lose, your budget, how often you can get injections, and side effects you can comfortably handle.
As of 2024, three GLP1 agonists have been approved for weight loss
